世界の非嚢胞性線維症気管支拡張症市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Non-Cystic Fibrosis Bronchiectasis Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4587
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、85ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、非嚢胞性線維症気管支拡張症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈注射）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・非嚢胞性線維症気管支拡張症の市場動向
・企業の競争状況、市場シェア
・非嚢胞性線維症気管支拡張症の種類別市場規模と予測2016-2027（経口、静脈注射）
・非嚢胞性線維症気管支拡張症の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・非嚢胞性線維症気管支拡張症の北米市場規模2016-2027（アメリカ、カナダ）
・非嚢胞性線維症気管支拡張症の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・非嚢胞性線維症気管支拡張症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・非嚢胞性線維症気管支拡張症の中南米市場規模2016-2027（メキシコ、ブラジル）
・非嚢胞性線維症気管支拡張症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Aradigm Corporation、Zambon、Novartis Pharmaceuticals、Insmed Incorporated）
・結論

Non-cystic fibrosis bronchiectasis (NCFB) is a chronic, progressive respiratory disorder characterized by irreversibly and abnormally dilated airways, persistent cough, excessive sputum production and recurrent pulmonary infections. The changes in the bronchial walls may be due to chronic inflammation secondary to recurrent or chronic infections in the lung, but often the exact cause is not identified.1 Symptoms vary from intermittent episodes of respiratory infections with excessive mucus production to chronic symptoms with persistent daily expectoration of purulent sputum. Non-cystic fibrosis bronchiectasis is associated with comorbidities such as anxiety, depression, fatigue, and has a significant impact on quality of life.

Market Analysis and Insights: Global Non-Cystic Fibrosis Bronchiectasis Market
The global Non-Cystic Fibrosis Bronchiectasis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Cystic Fibrosis Bronchiectasis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Cystic Fibrosis Bronchiectasis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Cystic Fibrosis Bronchiectasis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Cystic Fibrosis Bronchiectasis market.

Global Non-Cystic Fibrosis Bronchiectasis Scope and Market Size
Non-Cystic Fibrosis Bronchiectasis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Cystic Fibrosis Bronchiectasis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Intravenous

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Aradigm Corporation
Zambon
Novartis Pharmaceuticals
Insmed Incorporated

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Cystic Fibrosis Bronchiectasis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Intravenous
1.3 Market by Application
1.3.1 Global Non-Cystic Fibrosis Bronchiectasis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Non-Cystic Fibrosis Bronchiectasis Market Perspective (2016-2027)
2.2 Non-Cystic Fibrosis Bronchiectasis Growth Trends by Regions
2.2.1 Non-Cystic Fibrosis Bronchiectasis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-Cystic Fibrosis Bronchiectasis Historic Market Share by Regions (2016-2021)
2.2.3 Non-Cystic Fibrosis Bronchiectasis Forecasted Market Size by Regions (2022-2027)
2.3 Non-Cystic Fibrosis Bronchiectasis Industry Dynamic
2.3.1 Non-Cystic Fibrosis Bronchiectasis Market Trends
2.3.2 Non-Cystic Fibrosis Bronchiectasis Market Drivers
2.3.3 Non-Cystic Fibrosis Bronchiectasis Market Challenges
2.3.4 Non-Cystic Fibrosis Bronchiectasis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Non-Cystic Fibrosis Bronchiectasis Players by Revenue
3.1.1 Global Top Non-Cystic Fibrosis Bronchiectasis Players by Revenue (2016-2021)
3.1.2 Global Non-Cystic Fibrosis Bronchiectasis Revenue Market Share by Players (2016-2021)
3.2 Global Non-Cystic Fibrosis Bronchiectasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-Cystic Fibrosis Bronchiectasis Revenue
3.4 Global Non-Cystic Fibrosis Bronchiectasis Market Concentration Ratio
3.4.1 Global Non-Cystic Fibrosis Bronchiectasis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Cystic Fibrosis Bronchiectasis Revenue in 2020
3.5 Non-Cystic Fibrosis Bronchiectasis Key Players Head office and Area Served
3.6 Key Players Non-Cystic Fibrosis Bronchiectasis Product Solution and Service
3.7 Date of Enter into Non-Cystic Fibrosis Bronchiectasis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Cystic Fibrosis Bronchiectasis Breakdown Data by Type
4.1 Global Non-Cystic Fibrosis Bronchiectasis Historic Market Size by Type (2016-2021)
4.2 Global Non-Cystic Fibrosis Bronchiectasis Forecasted Market Size by Type (2022-2027)

5 Non-Cystic Fibrosis Bronchiectasis Breakdown Data by Application
5.1 Global Non-Cystic Fibrosis Bronchiectasis Historic Market Size by Application (2016-2021)
5.2 Global Non-Cystic Fibrosis Bronchiectasis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Non-Cystic Fibrosis Bronchiectasis Market Size (2016-2027)
6.2 North America Non-Cystic Fibrosis Bronchiectasis Market Size by Type
6.2.1 North America Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2021)
6.2.2 North America Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2022-2027)
6.2.3 North America Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2027)
6.3 North America Non-Cystic Fibrosis Bronchiectasis Market Size by Application
6.3.1 North America Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2021)
6.3.2 North America Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2022-2027)
6.3.3 North America Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2027)
6.4 North America Non-Cystic Fibrosis Bronchiectasis Market Size by Country
6.4.1 North America Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2016-2021)
6.4.2 North America Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Non-Cystic Fibrosis Bronchiectasis Market Size (2016-2027)
7.2 Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Type
7.2.1 Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2021)
7.2.2 Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2022-2027)
7.2.3 Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2027)
7.3 Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Application
7.3.1 Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2021)
7.3.2 Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2022-2027)
7.3.3 Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2027)
7.4 Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Country
7.4.1 Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2016-2021)
7.4.2 Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size (2016-2027)
8.2 Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Type
8.2.1 Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Application
8.3.1 Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Region
8.4.1 Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Non-Cystic Fibrosis Bronchiectasis Market Size (2016-2027)
9.2 Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Type
9.2.1 Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2021)
9.2.2 Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2022-2027)
9.2.3 Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2027)
9.3 Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Application
9.3.1 Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2021)
9.3.2 Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2022-2027)
9.3.3 Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2027)
9.4 Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Country
9.4.1 Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2016-2021)
9.4.2 Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size (2016-2027)
10.2 Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Type
10.2.1 Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Application
10.3.1 Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Country
10.4.1 Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Aradigm Corporation
11.1.1 Aradigm Corporation Company Details
11.1.2 Aradigm Corporation Business Overview
11.1.3 Aradigm Corporation Non-Cystic Fibrosis Bronchiectasis Introduction
11.1.4 Aradigm Corporation Revenue in Non-Cystic Fibrosis Bronchiectasis Business (2016-2021)
11.1.5 Aradigm Corporation Recent Development
11.2 Zambon
11.2.1 Zambon Company Details
11.2.2 Zambon Business Overview
11.2.3 Zambon Non-Cystic Fibrosis Bronchiectasis Introduction
11.2.4 Zambon Revenue in Non-Cystic Fibrosis Bronchiectasis Business (2016-2021)
11.2.5 Zambon Recent Development
11.3 Novartis Pharmaceuticals
11.3.1 Novartis Pharmaceuticals Company Details
11.3.2 Novartis Pharmaceuticals Business Overview
11.3.3 Novartis Pharmaceuticals Non-Cystic Fibrosis Bronchiectasis Introduction
11.3.4 Novartis Pharmaceuticals Revenue in Non-Cystic Fibrosis Bronchiectasis Business (2016-2021)
11.3.5 Novartis Pharmaceuticals Recent Development
11.4 Insmed Incorporated
11.4.1 Insmed Incorporated Company Details
11.4.2 Insmed Incorporated Business Overview
11.4.3 Insmed Incorporated Non-Cystic Fibrosis Bronchiectasis Introduction
11.4.4 Insmed Incorporated Revenue in Non-Cystic Fibrosis Bronchiectasis Business (2016-2021)
11.4.5 Insmed Incorporated Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Non-Cystic Fibrosis Bronchiectasis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Intravenous
Table 4. Global Non-Cystic Fibrosis Bronchiectasis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Non-Cystic Fibrosis Bronchiectasis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Non-Cystic Fibrosis Bronchiectasis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Non-Cystic Fibrosis Bronchiectasis Market Share by Regions (2016-2021)
Table 8. Global Non-Cystic Fibrosis Bronchiectasis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Non-Cystic Fibrosis Bronchiectasis Market Share by Regions (2022-2027)
Table 10. Non-Cystic Fibrosis Bronchiectasis Market Trends
Table 11. Non-Cystic Fibrosis Bronchiectasis Market Drivers
Table 12. Non-Cystic Fibrosis Bronchiectasis Market Challenges
Table 13. Non-Cystic Fibrosis Bronchiectasis Market Restraints
Table 14. Global Non-Cystic Fibrosis Bronchiectasis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Non-Cystic Fibrosis Bronchiectasis Market Share by Players (2016-2021)
Table 16. Global Top Non-Cystic Fibrosis Bronchiectasis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Cystic Fibrosis Bronchiectasis as of 2020)
Table 17. Ranking of Global Top Non-Cystic Fibrosis Bronchiectasis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Non-Cystic Fibrosis Bronchiectasis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Non-Cystic Fibrosis Bronchiectasis Product Solution and Service
Table 21. Date of Enter into Non-Cystic Fibrosis Bronchiectasis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Non-Cystic Fibrosis Bronchiectasis Revenue Market Share by Type (2016-2021)
Table 25. Global Non-Cystic Fibrosis Bronchiectasis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Non-Cystic Fibrosis Bronchiectasis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Non-Cystic Fibrosis Bronchiectasis Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Non-Cystic Fibrosis Bronchiectasis Revenue Market Share by Application (2016-2021)
Table 29. Global Non-Cystic Fibrosis Bronchiectasis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Non-Cystic Fibrosis Bronchiectasis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size by Country (2022-2027) & (US$ Million)
Table 61. Aradigm Corporation Company Details
Table 62. Aradigm Corporation Business Overview
Table 63. Aradigm Corporation Non-Cystic Fibrosis Bronchiectasis Product
Table 64. Aradigm Corporation Revenue in Non-Cystic Fibrosis Bronchiectasis Business (2016-2021) & (US$ Million)
Table 65. Aradigm Corporation Recent Development
Table 66. Zambon Company Details
Table 67. Zambon Business Overview
Table 68. Zambon Non-Cystic Fibrosis Bronchiectasis Product
Table 69. Zambon Revenue in Non-Cystic Fibrosis Bronchiectasis Business (2016-2021) & (US$ Million)
Table 70. Zambon Recent Development
Table 71. Novartis Pharmaceuticals Company Details
Table 72. Novartis Pharmaceuticals Business Overview
Table 73. Novartis Pharmaceuticals Non-Cystic Fibrosis Bronchiectasis Product
Table 74. Novartis Pharmaceuticals Revenue in Non-Cystic Fibrosis Bronchiectasis Business (2016-2021) & (US$ Million)
Table 75. Novartis Pharmaceuticals Recent Development
Table 76. Insmed Incorporated Company Details
Table 77. Insmed Incorporated Business Overview
Table 78. Insmed Incorporated Non-Cystic Fibrosis Bronchiectasis Product
Table 79. Insmed Incorporated Revenue in Non-Cystic Fibrosis Bronchiectasis Business (2016-2021) & (US$ Million)
Table 80. Insmed Incorporated Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Cystic Fibrosis Bronchiectasis Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Intravenous Features
Figure 4. Global Non-Cystic Fibrosis Bronchiectasis Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Non-Cystic Fibrosis Bronchiectasis Report Years Considered
Figure 9. Global Non-Cystic Fibrosis Bronchiectasis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Non-Cystic Fibrosis Bronchiectasis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Non-Cystic Fibrosis Bronchiectasis Market Share by Regions: 2020 VS 2027
Figure 12. Global Non-Cystic Fibrosis Bronchiectasis Market Share by Regions (2022-2027)
Figure 13. Global Non-Cystic Fibrosis Bronchiectasis Market Share by Players in 2020
Figure 14. Global Top Non-Cystic Fibrosis Bronchiectasis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Cystic Fibrosis Bronchiectasis as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Non-Cystic Fibrosis Bronchiectasis Revenue in 2020
Figure 16. Global Non-Cystic Fibrosis Bronchiectasis Revenue Market Share by Type (2016-2021)
Figure 17. Global Non-Cystic Fibrosis Bronchiectasis Revenue Market Share by Type (2022-2027)
Figure 18. North America Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Non-Cystic Fibrosis Bronchiectasis Market Share by Type (2016-2027)
Figure 20. North America Non-Cystic Fibrosis Bronchiectasis Market Share by Application (2016-2027)
Figure 21. North America Non-Cystic Fibrosis Bronchiectasis Market Share by Country (2016-2027)
Figure 22. United States Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Non-Cystic Fibrosis Bronchiectasis Market Share by Type (2016-2027)
Figure 26. Europe Non-Cystic Fibrosis Bronchiectasis Market Share by Application (2016-2027)
Figure 27. Europe Non-Cystic Fibrosis Bronchiectasis Market Share by Country (2016-2027)
Figure 28. Germany Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Share by Region (2016-2027)
Figure 38. China Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Non-Cystic Fibrosis Bronchiectasis Market Share by Type (2016-2027)
Figure 46. Latin America Non-Cystic Fibrosis Bronchiectasis Market Share by Application (2016-2027)
Figure 47. Latin America Non-Cystic Fibrosis Bronchiectasis Market Share by Country (2016-2027)
Figure 48. Mexico Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Market Share by Country (2016-2027)
Figure 54. Turkey Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Non-Cystic Fibrosis Bronchiectasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Aradigm Corporation Revenue Growth Rate in Non-Cystic Fibrosis Bronchiectasis Business (2016-2021)
Figure 58. Zambon Revenue Growth Rate in Non-Cystic Fibrosis Bronchiectasis Business (2016-2021)
Figure 59. Novartis Pharmaceuticals Revenue Growth Rate in Non-Cystic Fibrosis Bronchiectasis Business (2016-2021)
Figure 60. Insmed Incorporated Revenue Growth Rate in Non-Cystic Fibrosis Bronchiectasis Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

以下、関連資料のご紹介

世界の嚢胞性線維症診断検査市場規模・現状・予測（2021年-2027年）

Global Cystic Fibrosis Diagnostic Tests Market Size, Status and Forecast 2021-2027
QFJ1-4090 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、嚢胞性線維症診断検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子検査、糞便検査、免疫反応性トリプシノーゲン（IRT）検査、塩化汗検査、呼吸機能検査）、用途別市場規模（病院、診断研究所、その他...

世界の嚢胞性線維症治療市場規模・現状・予測（2021年-2027年）

Global Cystic Fibrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4091 2021年6月 127Pages
QYResearch社発行の本調査レポートでは、嚢胞性線維症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南ア...

世界の気管支拡張症薬市場規模・現状・予測（2021年-2027年）

Global Bronchiectasis Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5637 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、気管支拡張症薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、去痰薬、その他）、用途別市場規模（病院、研究所、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の気管支拡張症治療市場規模・現状・予測（2021年-2027年）

Global Bronchiectasis Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-3943 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、気管支拡張症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、去痰薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の嚢胞性にきび治療市場規模・現状・予測（2021年-2027年）

Global Cystic Acne Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4089 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、嚢胞性にきび治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（局所薬、レーザー治療、マイクロダーマブレーション、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、...

世界の後腹膜線維症治療市場規模・現状・予測（2021年-2027年）

Global Retroperitoneal Fibrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5993 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、後腹膜線維症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、免疫抑制剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の皮膚線維症治療市場規模・現状・予測（2021年-2027年）

Global Treatment of Skin Fibrosis Market Size, Status and Forecast 2021-2027
QFJ1-6052 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、皮膚線維症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗線維化剤、免疫療法薬、その他）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の皮膚線維症治療薬市場規模・現状・予測（2021年-2027年）

Global Cutaneous Fibrosis Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4077 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、皮膚線維症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗線維化薬、免疫グロブリン）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリ...

世界の心筋線維症市場規模・現状・予測（2021年-2027年）

Global Myocardial Fibrosis Market Size, Status and Forecast 2021-2027
QFJ1-4542 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、心筋線維症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小分子治療法、タンパク質治療法、ペプチド治療法、エンドグリン抗体療法法、幹細胞治療法、RNA治療法、その他）、用途別市場規模（病院、クリニック...

世界の後天性嚢胞性腎疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Acquired Cystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3750 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、後天性嚢胞性腎疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬、その他）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ...

世界の嚢胞性線維症診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cystic Fibrosis Diagnostic Tests Market The global Cystic Fibrosis Diagnostic Tests market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
世界の嚢胞性線維症治療市場規模・現状・予測（2021年-2027年） Cystic fibrosis (CF) is a hereditary disease characterized by abnormalities in the body's salt, aquatic cells, and mucus-producing cells. Market Analysis and Insights: Global Cystic Fibrosis Treatment Market The global Cystic Fibrosis Treatment market size is projected to reach US$ XX million by 202…
世界の気管支拡張症薬市場規模・現状・予測（2021年-2027年） Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bac…
世界の気管支拡張症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bronchiectasis Therapeutic Market The global Bronchiectasis Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …
気管支拡張薬のグローバル市場：規模・現状・予測2019-2025 Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bac…